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Background: Nontuberculous mycobacteria (NTM) are found ubiquitously in the environment. Since exposure to
NTM is universal, infection likely represents underlying host susceptibility factors. Anti-IFN-ɣ autoantibodies have
been described previously in patients with NTM. Up to 88 % of patients with disseminated NTM or other
opportunistic infections have high-titer anti-IFN-ɣ autoantibodies, compared with 2 % of patients with TB and
healthy controls.
Findings: We report a unique presentation of a patient with anti-IFN-ɣ autoantibodies with disseminated NTM
infection who presents with panuveitis with multifocal retinitis and vasculitis. Treatment with systemic anti
tubercular therapy resulted in complete clinical resolution with good visual recovery.
Conclusions: Patients with anti-IFN-ɣ autoantibodies present with a novel syndrome that links autoimmunity and
immunodeficiency. This case emphasizes the importance of testing for anti-IFN-ɣ autoantibodies in patients with
disseminated mycobacterial infection.Background
Nontuberculous mycobacteria (NTM) are defined as
mycobacteria other than Mycobacterium tuberculosis
(MTB). NTM are found ubiquitously in the environment
in soil, dust, and water [1, 2]. NTM were once thought to
be nonpathogenic but are now known to cause a wide
variety of human diseases including infections of the eye
[3]. Since exposure to NTM is universal, infection likely
represents underlying host susceptibility factors [4].
Genetic defects have been identified, predominantly in the
setting of disseminated NTM infection, with numerous
defects involving the type 1 cytokine pathway [5–8].
Despite its ubiquitous nature, NTM infections are still
relatively uncommon. A review of 174 published case re-
ports and series on NTM ocular infections found that the* Correspondence: su_ling_ho@ttsh.com.sg
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the Creative Commons license, and indicate ifmost frequently reported type of infection caused by NTM
was keratitis (290 of 420 eyes; 69 %). On the other hand,
the reported incidence of NTM infections causing choroidi-
tis were rare (6 of 420 eyes; 1.5 %), as was the incidence of
panuveitis from NTM infections (2 of 420 eyes; 0.5 %) [9].
Anti-IFN-ɣ autoantibodies have been described previ-
ously in patients with tuberculosis (TB) and human
immunodeficiency virus (HIV) [10, 11], as well as dissemi-
nated mycobacterial and other infections [12, 13].
We report a unique case of a patient with anti-IFN-ɣ
autoantibodies with disseminated NTM infection who pre-
sents with panuveitis with multifocal retinitis and vasculitis.
Findings
Case presentation
A 55-year-old Malay female presented with bilateral
blurring of vision for 2 weeks associated with fever. Her
best-corrected Snellen’s visual acuity was 6/21 in the right
eye and 6/7.5 in the left eye. Pupils were equal andis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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The intraocular pressure was 17 mmHg in both eyes. On
slit lamp examination, the conjunctiva was mildly injected,
with anterior chamber (AC) cells of grade 2+ and flare of
grade 1+ in both eyes, with a Koeppe nodule noted on the
left iris. Both lens had nuclear sclerotic cataract.
Posterior segment examination revealed vitritis, which
was more marked in the right eye. The optic discs in both
eyes were swollen. The macula appeared unremarkable in
both eyes with no evidence of cystoid macular edema.
There was peripheral vascular sheathing with vitreous and






Fig. 1 Right fundus photographs. Colour fundus photography demonstrate
retinal infiltrates at baseline in the posterior pole (a) and nasal retina (b). D
posterior pole (c) and nasal retina (d) as well as further improvement at weA review of her past medical history revealed that two
and a half years ago, she had been diagnosed with
pulmonary TB and Mycobacterium foruitum (M. fortuitum)
lymphadenitis when she presented with prolonged fever,
cough, weight loss, and generalized lymphadenopathy.
Sputum cultures were positive for MTB and she completed
9 months of treatment with rifampicin, isoniazid, and eth-
ambutol. A biopsy of her right axillary lymph node grew M.
fortuitum sensitive to moxifloxacin, amikacin, ciprofloxacin,
and cotrimoxazole. She received induction therapy with
6 weeks of intravenous amikacin followed by 9 months of
oral trimethoprim/sulphamethoxazole and levofloxacin.b
d
f
s the presence of peripheral vascular sheathing with vitreous and
ecreasing vitritis and activity of the retinal infiltrates at week 1 in the







Fig. 2 Left fundus photographs. Colour fundus photography demonstrates the presence of peripheral vascular sheathing with vitreous and
retinal infiltrates at baseline in the posterior pole (a) and nasal retina (b). Decreasing vitritis and activity of the retinal infiltrates at week 1 in the
posterior pole (c) and nasal retina (d) as well as further improvement at week 6 posterior pole (e) and nasal retina (f)
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performed and reported suppurative granulomatous
lymphadenitis with a few acid fast bacilli. However, the
polymerase chain reaction test (PCR) was negative for
TB bacilli.
After taking oral trimethoprim/sulphamethoxazole and
levofloxacin for 9 months, she defaulted her medications
for 3 months and represented with pyrexia and weight
loss. The third and latest biopsy of the right inguinal
lymph node grew Mycobacterium abscessus (M. abscessus)
sensitive to amikacin and clarithromycin. This was
accompanied by positive blood cultures for M. abscessus.
She received a further 6 weeks of induction therapy with
intravenous amikacin and cefoxitin, followed by orallevofloxacin, trimethoprim/sulphamethoxazole, and clari-
thromycin. No MTB treatment was given.
After 1 year of oral treatment for M. abscessus, she
decided to stop her medication after a discussion with
her infectious diseases physician citing pill burden and
financial concerns. Three months later, she represented
with her current complaints of pyrexia and bilateral
blurring of vision.
She was seronegative for HIV and had normal CD4:CD8
counts. Her syphilis rapid plasma reagin and syphilis
immunoglobulin G tests were negative. Further inves-
tigations found that she tested positive for anti-IFN-ɣ
autoantibodies, which completely inhibited downstream
phosphorylation of STAT-1 by IFN-ɣ (Fig. 3).
Fig. 3 Report. IFN-ɣ stimulation of STAT-1 phosphorylation. Peripheral
blood mononuclear cells were stimulated with IFN-ɣ and the level of
phospho-STAT1 measured by flow cytometry in culture media (red
histogram), the presence of patient’s plasma (blue histogram), or control
plasma (green histogram)
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bilateral disc leakage and peripheral perivascular leakage
(Figs. 4a,b and 5a,b). Indocyanine green angiography
(ICG) showed patches of hypocyanescence correspond-
ing to the blocked fluorescence from retinal infiltrates
(Figs. 4c,d and 5c, d). Spectral domain optical coherence
tomography (SD OCT) showed a normal foveal contour
with no cystoid macular edema with focal areas of
retinal thickening corresponding to the retinal infiltrates
on clinical examination (Figs. 4e and 5e). A second
computed tomography scan of her neck, thorax,
abdomen, and pelvis showed that some of her abdominal
and para-aortic lymph nodes had increased in size.
With the above clinical history and findings, and her
history of recurrent presentations of pyrexia 3 months
after stopping NTM treatment, the patient was diagnosed
with panuveitis with multifocal retinitis and vasculitis
likely secondary to NTM infection with a background of
anti-IFN-ɣ autoantibodies. Besides topical steroids and
antibiotic eye drops, the patient was started on empirical
treatment for M. abscessus. This included 6 weeks of
induction therapy with intravenous amikacin, intravenous
cefoxitin, and oral clarithromycin. In view of her history
of MTB and the presence of bilateral panuveitis, the
decision was made to treat empirically for MTB until
blood and acid fast bacilli cultures returned. She was
started on oral rifampicin, isoniazid, and pyrazinamide
1 day after initiating NTM induction therapy. No form of
oral or parenteral corticosteroid was given.
Over the course of a week, she reported improvement
in her vision especially in her right eye to 6/12. Examin-
ation of both eyes revealed improvement in anterior
chamber cells to a grade 1+, with decreasing vitritis and
activity of the retinal infiltrates (Figs. 1c,d and 2c,d). Her
fever also resolved after 2 days of treatment. She
declined a vitreous tap opting to continue treatment for
M. abscessus for 6 weeks and MTB for 8 weeks.
After 6 weeks, her vision had improved to 6/7.5 on the
right eye and 6/6 on the left eye. No AC cells were noted.An examination of the posterior segment showed only
mild disc swelling with no vitritis and the retinal infiltrates
had resolved (Figs. 1e,f and 2e,f). She did not report any
fever, weight loss, or malaise. Her NTM treatment was
changed to oral trimethoprim/sulphamethoxazole, levo-
floxacin, and clarithromycin. A repeat computed tomog-
raphy of the neck, thorax, abdomen, and pelvis reported
that the previously prominent para-aortic lymph nodes
were smaller in size.
After 8 weeks, all repeat blood and acid fast bacilli
cultures returned negative results. In the absence of
evidence of MTB, MTB treatment was stopped and she
was continued on long term NTM treatment. Since
then, the patient has had no recurrences of pyrexia,
weight loss, or panuveitis while on NTM treatment. She
was offered treatment with rituximab for her anti-IFN-ɣ
autoantibodies, but declined.
Discussion
Patel et al. reported finding anti-IFN-ɣ autoantibodies in 6
of 35 patients with disseminated mycobacterial infection
and all 6 patients were females of East Asian descent [4].
These autoantibodies were high-titer, able to block
binding of native human interferon-ɣ (IFN-ɣ), inhibitory
to early aspects of IFN-ɣ signal transduction (STAT-1
phosphorylation), and inhibitory to some of the down-
stream biological consequences of IFN-ɣ binding (IFN-ɣ
dependent upregulation of TNF-α and IL-12 production)
[4]. Whether these autoantibodies are the cause or effect
of the disseminated MAC infection is still unclear, al-
though a study by Chi et al. on previously healthy Chinese
adults, suggests that anti-IFN-ɣ autoantibodies may be the
cause of the disseminated NTM infection [14].
More recently, Brown et al. reported high-titer anti-
IFN-ɣ autoantibodies in 88 % of patients with dissemi-
nated NTM or other opportunistic infections compared
to 2 % of patients with TB and healthy controls amongst
patients from Thailand and Taiwan. This may indicate
distinctive roles for IFN-ɣ in the control of different
mycobacterial species [15]. The paucity of anti-IFN-ɣ
autoantibodies in patients with TB alone suggests that
mycobacterial infection itself does not lead to the deve-
lopment of anti-IFN-ɣ autoantibodies [15]. Similarly,
patients with isolated pulmonary NTM do not have anti-
IFN-ɣ autoantibodies suggesting that mycobacterial de-
fence is also organ specific [15]. Both authors also found
that in patients with anti-IFN-ɣ autoantibodies, the NTM
were predominantly due to rapidly growing mycobacteria
[4, 15]. Rapidly growing mycobacteria include M.
abscessus, M. fortuitum, and M. chelonae. A recent study
in 2013 which analysed NTM isolates from respiratory
specimens of 20,182 patients from 62 laboratories across 6
continents found that amongst the rapid growers, M.
abscessus and M. fortuitum were the most commonly
Fig. 4 Baseline investigations of the right eye. Fundus fluorescein angiogram disc leakage (a) and peripheral perivascular leakage (b). Indocyanine
green angiography showing patches of hypocyanescence corresponding to the blocked fluorescence from retinal infiltrates (c) and nasal retina
(d). Spectral domain optical coherence tomography (SD OCT) shows a normal foveal contour with no cystoid macular edema with focal areas of
retinal thickening corresponding to the retinal infiltrates on clinical examination (e)
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were found to be highly prevalent in East Asia when com-
pared to the rest of the world [16].
In a review of 174 case reports and series on NTM
ocular infections published in 2015, Kheir et al. found
that of the 420 eyes concerned, 9 presented with uveitis(6 cases of choroiditis, 1 case of iridocyclitis, and 2 cases
of panuveitis). Of these 9 patients, 5 had HIV/AIDS, 3
had disseminated NTM infection, and 1 was secondary
to prior cataract and vitrectomy operation. No mention
was made regarding the cause of the disseminated NTM
in the 3 patients presenting with this infection [9]. As
Fig. 5 Baseline investigations of the left eye. Fundus fluorescein angiogram disc leakage (a) and peripheral perivascular leakage (b). Indocyanine
green angiography showing patches of hypocyanescence corresponding to the blocked fluorescence from retinal infiltrates (c) and nasal retina
(d). Spectral domain optical coherence tomography (SD OCT) shows a normal foveal contour with no cystoid macular edema with focal areas of
retinal thickening corresponding to the retinal infiltrates on clinical examination (e)
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a patient with anti-IFN-ɣ autoantibodies presenting with
panuveitis with multifocal retinitis and vasculitis with a
background of disseminated NTM infection.
We note that our patient was first diagnosed with
MTB, prior to the isolation of other NTM. Her under-
lying anti-IFN-ɣ autoantibodies could have made her
more susceptible to MTB. Indeed studies have shown alink between anti-IFN-ɣ autoantibodies and MTB
infection [17, 18]. We concluded that given the history
of treated MTB and the recent diagnoses of recurrent,
disseminated NTM, our diagnosis of ocular NTM,
without taking any vitreous samples for staining and
cultures, was a reasonable one. Nevertheless, upon
developing ocular involvement, the patient was treated
systemically with targeted therapy to both NTM and
Lee et al. Journal of Ophthalmic Inflammation and Infection  (2016) 6:39 Page 7 of 8MTB, without any systemic steroids. Clinical response
was good, with the patient reporting improvement
within a week and notable deterioration in the activity of
the retinal lesions. After 6 weeks of treatment with anti-
tuberculous therapy alone, there was a total resolution
of ocular lesions.
The fact that our patient has had multiple admissions
and treatment for NTM underlines the fact that such
infections tend to be recurrent in these patient popula-
tions. Close ophthalmic follow-up is imperative to detect
future recurrences of ocular involvement and treatment
to prevent any sequelae.
There were small case series of successful treatment of
this condition with the anti-CD20 monoclonal antibody,
rituximab. Browne et al. [19] reported the treatment of
four similar patients with multiple doses of rituximab,
resulting in the decline of the pathogenic auto-antibodies,
the recovery of IFN-ɣ-induced pSTAT-1 signalling, and
most importantly, the reduction in the incidence of
clinical infections. This patient was offered treatment with
rituximab but for personal reasons had declined this
option of treatment.Conclusion
Patients with anti-IFN-ɣ autoantibodies present with a
novel syndrome that links autoimmunity and immuno-
deficiency. This case emphasizes the importance of
testing for anti-IFN-ɣ autoantibodies in patients with
disseminated mycobacterial infection. Systemic anti
tubercular therapy resulted in complete clinical reso-
lution with good visual recovery.
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